CIK: 0001325083 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 14, 2019
Total Value ($000): $87,900 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Biohaven Pharmactl Hldg Co L | 749,815 | $27,728 | 31.5% | $25.00 | — | COM | G11196105 |
| — | Corbus Pharmaceuticals HLDGS | 4,062,791 | $23,727 | 27.0% | $4.54 | — | COM | 21833P103 |
| — | Abeona Therapeutics Inc | 2,359,767 | $16,849 | 19.2% | $4.97 | — | COM | 00289Y107 |
| KRYS | Krystal Biotech Inc | 300,000 | $6,234 | 7.1% | $10.08 | +107.7% | COM | 501147102 |
| ALDX | Aldeyra Therapeutics Inc | 484,096 | $4,018 | 4.6% | $8.65 | +18.5% | COM | 01438T106 |
| — | Electrocore Inc | 396,825 | $2,484 | 2.8% | $16.51 | — | COM | 28531P103 |
| ENTX | Entera Bio Ltd | 475,540 | $1,450 | 1.6% | $6.29 | -19.9% | SHS | M40527109 |
| — | Galmed Pharmaceuticals Ltd | 210,000 | $1,434 | 1.6% | $11.90 | — | SHS | M47238106 |
| AVXL | Anavex Life Sciences Corp | 724,205 | $1,130 | 1.3% | $3.56 | -36.3% | COM NEW | 032797300 |
| — | Eiger Biopharmaceuticals Inc | 75,238 | $764 | 0.9% | $9.85 | — | COM | 28249U105 |
| — | Soligenix Inc. | 837,800 | $721 | 0.8% | $2.11 | — | COM | 834223307 |
| — | Evoke Pharma Inc | 275,000 | $682 | 0.8% | $2.99 | — | COM | 30049G104 |
| — | Molecular Templates | 113,905 | $460 | 0.5% | $4.04 | — | COM | 608550109 |
| NAGE | Chromadex Corp | 45,019 | $154 | 0.2% | $3.80 | -8.5% | COM NEW | 171077407 |
| — | Lipocine Inc New | 50,000 | $65 | 0.1% | $1.30 | — | COM | 53630X104 |